Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
898,529
-
Share change
-
-38,168
-
Total reported value
-
$847,784
-
Price per share
-
$0.95
-
Number of holders
-
30
-
Value change
-
-$34,051
-
Number of buys
-
9
-
Number of sells
-
16
Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q2 2024
As of 30 Jun 2024,
MiNK Therapeutics, Inc. - Stock (INKT) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
898,529 shares.
The largest 10 holders included
VANGUARD GROUP INC, Longbow Finance SA, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., HighTower Advisors, LLC, CAPTRUST FINANCIAL ADVISORS, STATE STREET CORP, GOLDMAN SACHS GROUP INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.